You are here: Home/Webinars/ Cell and Gene Therapy in the Time of COVID-19 – An Imperative for Innovation

Cell and Gene Therapy in the Time of COVID-19 – An Imperative for Innovation

Event Date: May 27, 2020

The world is currently faced with a pandemic of novel coronavirus disease 2019 (COVID-19), which is caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). Join our upcoming webinar to learn how to manage ongoing CAGT trials, get an overview of the epidemiology, pathophysiology, and clinical manifestations of COVID-19, the application of cell and gene therapies (CAGT) to this disease, new CAGT for COVID-19 on the horizon, and key considerations for CAGT trials. Hear lessons learned conducting CAGT trials during the early period of the COVID-19 crisis that may help in planning for the future.

Support & Contact

About

Stay Connected

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.